These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 4796001

  • 1. Antibody cytotoxicity studies in ovarian and cervical malignancies.
    Disaia PJ, Nalick RH, Townsend DE.
    Obstet Gynecol; 1973 Nov; 42(5):644-50. PubMed ID: 4796001
    [No Abstract] [Full Text] [Related]

  • 2. Immunological aspects of gynecological malignancies.
    DiSaia PJ.
    J Reprod Med; 1975 Jan; 14(1):17-20. PubMed ID: 1110478
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. An immunologic comparison between serous cystadenocarcinoma of the ovary and other human gynecologic tumors.
    Bhattacharya M, Barlow JJ.
    Am J Obstet Gynecol; 1973 Nov 15; 117(6):849-53. PubMed ID: 4126800
    [No Abstract] [Full Text] [Related]

  • 5. Inhibition of colony formation by cytotoxic antibodies in cervical epidermoid carcinoma.
    Byfield JE, Weintraub I, Klisak I, Lagasse LD.
    Radiology; 1973 Jun 15; 107(3):685-6. PubMed ID: 4735695
    [No Abstract] [Full Text] [Related]

  • 6. Evidence for specific tumor cytotoxic antibodies in serum of cervical cancer patients.
    Weintraub I, Klisak I, Lagasse LD, Byfield JE.
    Am J Obstet Gynecol; 1973 Aug 01; 116(7):985-92. PubMed ID: 4124024
    [No Abstract] [Full Text] [Related]

  • 7. Cell-mediated immune reaction to two gynecologic malignant tumors.
    DiSala PJ, Rutledge FN, Smith JP, Sinkovics JG.
    Cancer; 1971 Nov 01; 28(5):1129-37. PubMed ID: 5125661
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. ABO antigens in cancer. Detection with the mixed cell agglutination reaction.
    Kovarik S, Davidsohn I, Stejskal R.
    Arch Pathol; 1968 Jul 01; 86(1):12-21. PubMed ID: 5690174
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The association of RCAS1 serum concentration with the reversibility or irreversibility of the process of immune cytotoxic activity restriction during normal menstrual cycle, cancer relapse, and surgical treatment for various types of squamous cell carcinomas and adenocarcinomas.
    Dutsch-Wicherek M, Wicherek L.
    Am J Reprod Immunol; 2008 Mar 01; 59(3):266-75. PubMed ID: 18275520
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Differential diagnosis of pleural effusions].
    Ogino M, Koike K, Satoh K, Arai K.
    Gan To Kagaku Ryoho; 1984 Sep 01; 11(9):1770-4. PubMed ID: 6476843
    [Abstract] [Full Text] [Related]

  • 18. [Comparative study of total 17-ketosteroids and free 17-hydroxycorticosteroids in the plasma of women with carcinoma of the cervix, the uterus, or the ovary].
    Bénard H, Bourdin JS, Saracino R, Seeman A.
    Rev Fr Etud Clin Biol; 1968 Nov 01; 13(9):853-9. PubMed ID: 5709510
    [No Abstract] [Full Text] [Related]

  • 19. [Production of monoclonal antibody (MCA-97) to endometrial adenocarcinoma].
    Inoue M, Saito J, Abe Y, Tanako Y, Ueda G, Tanizawa O.
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Mar 01; 37(3):433-4. PubMed ID: 3981049
    [No Abstract] [Full Text] [Related]

  • 20. [Antigenic specificity of the polysaccharide fraction of ovarian adenocarcinoma in the delayed hypersensitivity reaction].
    Ul'chenko VM, Gorodilova VV, Bashkaev IS.
    Vopr Onkol; 1976 Mar 01; 22(3):3-7. PubMed ID: 936525
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.